Stock Events

Stock Events

Bristol-Myers Squibb 

$0.08
8433
+$0.01+8% Friday 20:39

Statistics

Day High
0.1
Day Low
0.08
52W High
0.1
52W Low
0.08
Volume
11,852
Avg. Volume
-
Mkt Cap
164.9M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5FebExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Next
1.09
1.33
1.56
1.8
Expected EPS
1.226038
Actual EPS
N/A

Financials

-18.53%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
96.6BRevenue
-17.9BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CELG-RI. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap140.15B
Pfizer competes directly in various therapeutic areas including oncology, immunology, and cardiovascular diseases.
Merck
MRK
Mkt Cap214.76B
Merck & Co. is a key competitor in the pharmaceutical industry, especially in the oncology segment with its blockbuster cancer drug Keytruda.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson competes across multiple segments including pharmaceuticals, with a strong presence in immunology and oncology.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie competes in areas like immunology and oncology, directly challenging Bristol-Myers Squibb's product lineup.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline competes in the pharmaceutical and healthcare sector, with a focus on respiratory diseases, HIV, and vaccines.
Novartis
NVS
Mkt Cap237.61B
Novartis is a global healthcare company that competes in various therapeutic areas including cardiovascular, oncology, and immunology.
AMGEN
AMGN
Mkt Cap160.66B
Amgen competes in the biopharmaceutical sector, focusing on human therapeutics, including treatments for cancer and cardiovascular disease.
Sanofi
SNY
Mkt Cap124.45B
Sanofi competes in the global pharmaceutical market, with a focus on diabetes, oncology, and rare diseases.
Roche
RHHBY
Mkt Cap258.9B
Roche Holding AG competes in the pharmaceutical and diagnostics sectors, with a strong emphasis on oncology and immunology.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca is a global, science-led biopharmaceutical business that competes in core areas of healthcare, including oncology, cardiovascular, renal, and metabolism.

About

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.
Show more...
CEO
Employees
34100
Country
US
ISIN
US1101221406

Listings

MI
IT
1BMY.MI
XETRA
DE
BRM.XETRA
SA
BR
BMYB34.SA
BA
AR
BMYD.BA

0 Comments

Share your thoughts

FAQ

What is Bristol-Myers Squibb stock price today?▼
The current price of CELG-RI is $0.08 USD — it has increased by +8% in the past 24 hours. Watch Bristol-Myers Squibb stock price performance more closely on the chart.
What is Bristol-Myers Squibb stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Bristol-Myers Squibb stocks are traded under the ticker CELG-RI.
What is Bristol-Myers Squibb market cap?▼
Today Bristol-Myers Squibb has the market capitalization of 164.9M
When is the next Bristol-Myers Squibb earnings date?▼
Bristol-Myers Squibb is going to release the next earnings report on February 05, 2026.
What were Bristol-Myers Squibb earnings last quarter?▼
CELG-RI earnings for the last quarter are 1.63 USD per share, whereas the estimation was 1.52 USD resulting in a +7.41% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Bristol-Myers Squibb revenue for the last year?▼
Bristol-Myers Squibb revenue for the last year amounts to 96.6B USD.
What is Bristol-Myers Squibb net income for the last year?▼
CELG-RI net income for the last year is -17.9B USD.
How many employees does Bristol-Myers Squibb have?▼
As of February 02, 2026, the company has 34,100 employees.
When did Bristol-Myers Squibb complete a stock split?▼
Bristol-Myers Squibb has not had any recent stock splits.